[go: up one dir, main page]

ATE229946T1 - Alpha-1 adrenergischer rezeptor antagonisten - Google Patents

Alpha-1 adrenergischer rezeptor antagonisten

Info

Publication number
ATE229946T1
ATE229946T1 AT97919488T AT97919488T ATE229946T1 AT E229946 T1 ATE229946 T1 AT E229946T1 AT 97919488 T AT97919488 T AT 97919488T AT 97919488 T AT97919488 T AT 97919488T AT E229946 T1 ATE229946 T1 AT E229946T1
Authority
AT
Austria
Prior art keywords
alpha
receptor antagonists
adrenergic receptor
derivatives
alpha1
Prior art date
Application number
AT97919488T
Other languages
English (en)
Inventor
Dennis Bigg
De Lassauniere Pierre Charbier
Serge Auvin
Merisierss
Michel Auguet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE229946T1 publication Critical patent/ATE229946T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
AT97919488T 1996-04-05 1997-04-04 Alpha-1 adrenergischer rezeptor antagonisten ATE229946T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62827696A 1996-04-05 1996-04-05
PCT/FR1997/000615 WO1997037983A1 (fr) 1996-04-05 1997-04-04 ANTAGONISTES DU RECEPTEUR α1-ADRENERGIQUE

Publications (1)

Publication Number Publication Date
ATE229946T1 true ATE229946T1 (de) 2003-01-15

Family

ID=24518205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97919488T ATE229946T1 (de) 1996-04-05 1997-04-04 Alpha-1 adrenergischer rezeptor antagonisten

Country Status (15)

Country Link
US (1) US6300499B1 (de)
EP (1) EP0891344B1 (de)
JP (1) JP3845452B2 (de)
AT (1) ATE229946T1 (de)
AU (1) AU2393997A (de)
CZ (1) CZ315098A3 (de)
DE (1) DE69717978T2 (de)
DK (1) DK0891344T3 (de)
ES (1) ES2188936T3 (de)
HU (1) HUP9901680A3 (de)
IL (1) IL126411A0 (de)
NO (1) NO984631L (de)
PL (1) PL329190A1 (de)
RU (1) RU2179554C2 (de)
WO (1) WO1997037983A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661163A (en) * 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
GB9819860D0 (en) 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
EA200401335A1 (ru) * 2002-04-08 2006-02-24 Ранбакси Лабораторис Лимитед Производные карбоксимида в качестве уроселективных блокаторов альфа-1a адренорецепторов
ES2280799T3 (es) * 2002-07-04 2007-09-16 Schwarz Pharma Ag Heteroarencarboxamidas para su utilizacion como ligandos de dopamina-d3 para el tratamiento enfermedades del snc (sistema nervioso central).
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2006021344A1 (en) * 2004-08-27 2006-03-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with alpha-1a adrenergic receptor (adra1a)
WO2013038427A1 (en) * 2011-09-12 2013-03-21 Council Of Scientific & Industrial Research ARYLATED β-DICARBOIMYL COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF
CN103288745A (zh) * 2013-06-25 2013-09-11 南方医科大学 一种2,6-二取代哒嗪酮类化合物及其应用
CN103304486A (zh) * 2013-06-25 2013-09-18 南方医科大学 6-（4-芳基哌嗪-1-基）哒嗪-3（2h）-酮及其应用
WO2015029447A1 (ja) * 2013-08-30 2015-03-05 興和株式会社 光学活性カルビノール化合物の製造方法
CN115124415A (zh) * 2022-06-20 2022-09-30 西咸新区行易先进材料科技有限公司 一种合成阿卓乳酸的催化反应方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2722529A (en) * 1955-11-01 Amides of certain l-amevoalkyl-x-phenyl
US2833770A (en) * 1958-05-06 Chj-chj
NL8005133A (nl) 1980-09-12 1982-04-01 Duphar Int Res Fenylpiperazinederivaten met antiagressieve werking.
IL90279A (en) 1988-05-24 1995-03-30 American Home Prod Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them
PT93824B (pt) * 1989-04-22 1996-09-30 Wyeth John & Brother Ltd Processo para a preparacao de derivados de piperazina
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE4121276C2 (de) 1991-06-27 1994-02-17 Metallgesellschaft Ag Verfahren zur Herstellung sulfathaltiger, basischer Polyaluminiumchlorid-Lösungen
GB9200293D0 (en) 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
US5284990A (en) 1992-07-16 1994-02-08 Stratco, Inc. Method for converting a hydrogen fluoride alkylation unit to a sulfuric acid alkylation unit
US5349844A (en) 1992-09-11 1994-09-27 Trc Companies, Inc. System and method for resonant filter mass monitoring
SE9300295D0 (sv) 1993-01-28 1993-01-28 Benny Carlstroem Foerfarande och anordning foer bindning av tandlagningsmaterial
EP0714292A4 (de) * 1993-06-23 1996-10-09 Cambridge Neuroscience Inc Sigma-rezeptor-liganden und ihre verwendung
US5414585A (en) 1993-07-19 1995-05-09 Quantum Corp. Rotating tape edge guide
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
US5696123A (en) * 1994-09-17 1997-12-09 Boehringer Ingelheim Kg Neurokinin antagonists

Also Published As

Publication number Publication date
PL329190A1 (en) 1999-03-15
EP0891344B1 (de) 2002-12-18
NO984631L (no) 1998-12-02
EP0891344A1 (de) 1999-01-20
RU2179554C2 (ru) 2002-02-20
HUP9901680A2 (hu) 1999-09-28
JP2000508310A (ja) 2000-07-04
NO984631D0 (no) 1998-10-02
DE69717978T2 (de) 2003-10-02
DK0891344T3 (da) 2003-04-07
IL126411A0 (en) 1999-05-09
DE69717978D1 (de) 2003-01-30
CZ315098A3 (cs) 1999-04-14
WO1997037983A1 (fr) 1997-10-16
HUP9901680A3 (en) 2000-12-28
AU2393997A (en) 1997-10-29
ES2188936T3 (es) 2003-07-01
US6300499B1 (en) 2001-10-09
JP3845452B2 (ja) 2006-11-15

Similar Documents

Publication Publication Date Title
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
MX9705674A (es) Antagonistas hexahidrobenz(e)isoindol alfa-1 adrenergicos, triciclos substituidos.
ATE228502T1 (de) Substituierte analoge von indol-3-carbinol und von diindolmethan als antiestrogene
NO922683L (no) Fremgangsmaate for hydrogenering av glyserol
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
HK1029922A1 (en) Angiostatic agents and compositions for treating glc1a glaucoma
ATE229946T1 (de) Alpha-1 adrenergischer rezeptor antagonisten
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
NZ234414A (en) A method of prophylaxis and/or treatment of benign prostatic hyperplasia (bph)
BR9811099A (pt) Inibidores de urocinase
DK0805812T3 (da) Bicyklisk substitueret hexahydrobenz[e]isoindol som alfa-1-adrenerge antagonister
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
AU2443184A (en) Benzazocinones and benzazoninones
ZA986673B (en) Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders
EP0646007A4 (de)
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
BG103553A (en) Benzopyranopyrol and benzopyranopyridine alpha-1 adrenergic compounds
HUP0100781A2 (hu) A jóindulatú prosztata hiperplázia kezelésére alkalmas szubsztituált piridino aril piperazin-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
KR950700746A (ko) 양성 전립선 비대를 치료하는 조성물 및 방법(Compositions and Methods For Treating Benign Prostatic Hypertrophy)
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
NO975838L (no) Melatoninagonister for behandling av godartet prostatisk hyperplasi
CA2251016A1 (fr) Antagonistes du recepteur .alpha.1-adrenergique
HUT67527A (en) Arylalkoxyphenoxy-imidazoline derivatives and pharmaceutical compositions containing them
NO992110L (no) Syntese av benzo[f]kinoliner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0891344

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee